CENTENNIAL, Colo.--(BUSINESS WIRE)--Inhibiton Therapeutics, Inc. (OTCBB: IHBT) announced today the appointment of Aaron A. Grunfeld to its board of directors as an independent director. Based in Los Angeles, California, Mr. Grunfeld is an attorney with his own law firm, the Law Offices of Aaron A. Grunfeld & Associates, where he has focused his law practice on securities and corporate matters, including domestic and international transactions, for more than 35 years. As counsel to individuals, corporate clients and investment bankers, Mr. Grunfeld has been involved in more than 50 registered public offerings while counseling clients on issues related to corporate compliance and regulatory issues, merger and reorganization transactions, private placements and other related matters. Mr. Grunfeld received an A.B. in Political Science from UCLA in 1968 and a J.D. from Columbia University in 1971.
